Skip to main content
SpringerLink
Log in

Case Report: Effectiveness of Lamivudine in Treatment of Acute Recurrent Hepatitis B After Liver Transplantation

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Wright TL: Liver transplantation in patients with chronic hepatitis B and hepatitis C. InTransplantation of the Liver, 2nd ed. WC Maddrey, MF Sorrell (eds.). Norwalk, Appleton & Lange, 1995, pp 477- 501

    Google Scholar 

  2. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H: Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 329:1842- 1847, 1993

    Google Scholar 

  3. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson MI, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, Hepatitis Interventional Therapy Group: A randomized, controlled trial of interferon alfa-2b alone after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323:295- 301, 1990

    Google Scholar 

  4. Terrault NA, Combs Holland C, Ferrell L, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL: Interferon alfa for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 2:132- 138, 1996

    Google Scholar 

  5. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M: A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657- 1661, 1995

    Google Scholar 

  6. Lai CL, Liaw YF, Leung NWY, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent JC, Gray DF: 12 months of lamivudine (100 mg od) therapy improves liver histology: Results of a placebo controlled multicentre study in Asia. J Hepatol 26(suppl 1):79, 1997

    Google Scholar 

  7. Benhamou Y, Dohin E, Luniel-Fabiani F, Poynard T, Huraux JM, Katlama C, et al: Efficacy of lamivudine in replication of hepatitis B virus in HIV-infected patients. Lancet 345:396–397, 1995

    Google Scholar 

  8. Grellier L, Mutimer D, Ahmed M, Brown D, Burroughs AK, Rolles K, McMaster P, Beranek P, Kennedy F, Kibbler H, McPhillips P, Elias E, Dusheiko G: Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 348:1212- 1215, 1996

    Google Scholar 

  9. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE, Hoofnagle JH: Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for hepatitis B. N Engl J Med 333:1099 - 1105, 1995

    Google Scholar 

  10. Samue l D, Bismuth A, Mathieu D, Arulnaden J, Raynes M, Benhamou J, Brechot C, et al: Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 337:813- 815, 1991

    Google Scholar 

  11. Lau JYN, Davies SE, Bain VG, O'Grady JG, Alberti A, Alexander GJM, Williams R: High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 102:956 - 962, 1992

    Google Scholar 

  12. Marcellin P, Samuel D, Loriot MA, Areias J, Bismuth H, Benhamou JP: Antiviral effect of adenine arabinoside monophosphate (ARA-AMP) in patients with recurrence of hepatitis B virus (HBV) infection after liver transplantation. Hepatology 12:966A, 1990

    Google Scholar 

  13. Lok ASF, Wilson LA, Thomas HC: Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection. J Antimicrob Chemother 14:93- 99, 1984

    Google Scholar 

  14. Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC, Garcia-Kennedy R, et al: Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 23:1- 7, 1996

    Google Scholar 

  15. Rabinovitz M, Dodson F, Rakela J: Famciclovir for recurrent hepatitis B (HBV) infection after liver transplantation (OLTX). Hepatology 24:282A, 1996

    Google Scholar 

  16. Perrillo R, Rakela J, Martin P, Levy G, Schiff E, Wright T, Dienstag J, Gish R, Villeneuve J, Caldwell S, Brown N, Self P, Lamivudine Transplant Study Group: Lamivudine for hepatitis B after liver transplantation (OLT). Hepatology 24:182A, 1996

    Google Scholar 

Download references

Authors
  1. J. Ignacio Herrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge Quiroga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bruno Sangro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Iosu Sola
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jose Ignacio Riezu-Boj
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fernando Pardo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jesus Prieto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herrero, J.I., Quiroga, J., Sangro, B. et al. Case Report: Effectiveness of Lamivudine in Treatment of Acute Recurrent Hepatitis B After Liver Transplantation. Dig Dis Sci 43, 1186–1189 (1998). https://doi.org/10.1023/A:1018887203545

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018887203545

Search

Navigation